"Maximum intravenous alteplase dose for obese stroke patients is not as" by Star Belnap, Anshul Saxena et al.

Menu

Skip to main content

All Publications

Star Belnap, Miami Neuroscience InstituteFollow
Anshul Saxena, Baptist Health Medical GroupFollow
Emir Veledar, Baptist Health South FloridaFollow
Amy Starosciak, Miami Cancer InstituteFollow
Felipe De Los Rios La Rosa, Miami Neuroscience InstituteFollow

Maximum intravenous alteplase dose for obese stroke patients is not associated with greater likelihood of worse outcomes

Publication Date

8-1-2021

Content Type

Article

PubMed ID:

Additional Authors:

Additional authors and institutional affiliations

Citation

Thrombosis Research (2021) 204:76-80

Restricted

Available to BHSF community via local IP address or BHSF login.

Find in your library

COinS